Classified as a selective Nicotinamide N-methyltransferase (NNMT) small-molecule inhibitor, this quaternary ammonium compound achieves around 38.4% oral bioavailability in rodent trials, an acceptable absorption rate for positively charged quinolinium derivatives that typically face poor intestinal permeability
It is currently in Phase 1/2 development for obesity and T2D
Almigbal TH, Alzarah SA, Aljanoubi FA, Alhafez NA, Aldawsari MR, Alghadeer ZY, et al
These have the ability to manage the immune system and reduce pain
La carnitina lliure retorna al citosol
PHYSIOMANCE GLP-1 Protect stato appositamente formulato per essere associato a questi trattamenti, come accompagnamento nutrizionale, aumentando dunque la durata e il successo della terapia